0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xenograft"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Preclinical CRO Market Opportunities and Strategies to 2033 - Product Thumbnail Image

Preclinical CRO Market Opportunities and Strategies to 2033

  • Report
  • November 2024
  • 323 Pages
  • Global
From
EUR$3,500USDGBP
EUR$5,000USDGBP
Patient Derived Xenograft (PDX) Models Market Report 2024 - Product Thumbnail Image

Patient Derived Xenograft (PDX) Models Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
EUR$5,000USDGBP
Global Animal Model Market Report 2024 - Product Thumbnail Image

Global Animal Model Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
EUR$5,000USDGBP
From
EUR$4,950USDGBP
Drug Discovery Technologies Market Report 2025 - Product Thumbnail Image

Drug Discovery Technologies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Preclinical CRO Market Report 2025 - Product Thumbnail Image

Preclinical CRO Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Oncology Based in-Vivo CRO Market Report 2025 - Product Thumbnail Image

Oncology Based in-Vivo CRO Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$5,450USDGBP
Loading Indicator

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies. The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts. Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more